Kindred Biosciences (NASDAQ:KIN) +8.8% after-hours on news the Food and Drug Administration's Center for Veterinary Medicine approved Zimeta (dipyrone injection) for the control of pyrexia in horses.
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the U.S. Food and Drug Administration's Center for Veterinary Medicine has approved Zimetaâ„¢ (dipyrone injection) for the control of pyrexia in horses.
India’s Ministry of Health and Family Welfare informed India’s Upper House of Parliament, Rajya Sabha, that safety issues involving drugs that may be banned in another country are reviewed with experts prior to making a final determination of continued marketing.
Anvisa suspends lots of drugs Chemical Union
Anvisa suspends batch of sodium Dipyrone of Pharmaceutical Biochemical Pharmaceutical Industry Cearense Ltd
Sanofi sues decision aid maker for ‘injurious falsehood’
Anvisa Suspends Distribution of Ceara Ltds’ Injectable Products on Failing the Look Test